MENU
FMS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

FMS stock forecast, quote, news & analysis

Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025... Show more

FMS
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for FMS with price predictions
Aug 07, 2026

FMS sees MACD Histogram just turned negative

FMS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 04, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for FMS moved out of overbought territory on August 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FMS as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FMS broke above its upper Bollinger Band on July 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 50-day moving average for FMS moved above the 200-day moving average on July 23, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FMS advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 250 cases where FMS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.890) is normal, around the industry mean (238.796). P/E Ratio (12.651) is within average values for comparable stocks, (122.863). Projected Growth (PEG Ratio) (0.853) is also within normal values, averaging (1.766). FMS has a moderately high Dividend Yield (0.036) as compared to the industry average of (0.014). P/S Ratio (0.606) is also within normal values, averaging (2.689).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
published Dividends

FMS paid dividends on June 08, 2026

Fresenius Medical Care AG FMS Stock Dividends
А dividend of $0.87 per share was paid with a record date of June 08, 2026, and an ex-dividend date of May 22, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 4.85B. The market cap for tickers in the group ranges from 48.5K to 89.49B. HCA holds the highest valuation in this group at 89.49B. The lowest valued company is BYZN at 48.5K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was 3%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 40%. STLN experienced the highest price growth at 32%, while BTMD experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was 30%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 50
Price Growth Rating: 49
SMR Rating: 66
Profit Risk Rating: 88
Seasonality Score: -18 (-100 ... +100)
View a ticker or compare two or three
FMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of renal and dialysis products

Industry HospitalNursingManagement

Profile
Details
Industry
Medical Or Nursing Services
Address
Else-Kroener-Strasse 1
Phone
+49 791033353
Employees
119845
Web
https://www.freseniusmedicalcare.com
FMS sees MACD Histogram just turned negative